SCHEMBL6644277

SCHEMBL6644277

O=C1Nc2ccccc2C2COCC12

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.44
NOS3 P29474 1/20 0.40
NOS1 P29475 1/20 0.40
NOS2 P35228 1/20 0.40
GSK3B P49841 2/20 0.40
ALDH1A1 P00352 2/20 0.39
PARP1 P09874 1/20 0.39
BRPF1 P55201 1/20 0.38
CREBBP Q92793 1/20 0.38
TDO2 P48775 1/20 0.38
KDM4E B2RXH2 3/20 0.38
NPC1 O15118 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
MAPT P10636 4/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
GAA P10253 1/20 0.37
RAB9A P51151 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22907690 0.79 IDO1 (0.47) IDO1GSK3BALDH1A1PARP1BRPF1
SCHEMBL19696036 0.79 IDO1 (0.47) IDO1GSK3BALDH1A1PARP1BRPF1
SCHEMBL2764856 0.79 IDO1 (0.47) IDO1GSK3BALDH1A1PARP1BRPF1
SCHEMBL30839791 0.79 IDO1 (0.47) IDO1GSK3BALDH1A1PARP1BRPF1
SCHEMBL19985146 0.79 IDO1 (0.47) IDO1GSK3BALDH1A1PARP1BRPF1
SCHEMBL23264408 0.79 IDO1 (0.47) IDO1GSK3BALDH1A1PARP1BRPF1
SCHEMBL7927054 0.76 IDO1 (0.45) IDO1NOS1GSK3BALDH1A1PARP1
SCHEMBL6137734 0.76 IDO1 (0.45) IDO1NOS3NOS1NOS2GSK3B
SCHEMBL4761869 0.76 IDO1 (0.45) IDO1NOS3NOS1NOS2GSK3B
SCHEMBL7252422 0.76 IDO1 (0.45) IDO1NOS1GSK3BALDH1A1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054869-B1 3,4-DIHYDROQUINOLINE DERIVATIVES AS NITROGEN MONOXIDE SYNTHASE (NOS) INHIBITORS SCHERING AG (DE) 2004-09-22 EP disclosed
US-6391887-B1 ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2002-05-21 US disclosed